首页 | 本学科首页   官方微博 | 高级检索  
   检索      

布林佐胺联合噻吗洛尔治疗开角型青光眼的临床效果观察及安全性评价
引用本文:刘 法,郝 静,陈志杰,刘 江,张晓磊,姚 靖.布林佐胺联合噻吗洛尔治疗开角型青光眼的临床效果观察及安全性评价[J].现代生物医学进展,2020(11):2189-2192.
作者姓名:刘 法  郝 静  陈志杰  刘 江  张晓磊  姚 靖
作者单位:哈尔滨二四二医院眼科 黑龙江 哈尔滨 150066;黑龙江省中医药大学成人教育学院 黑龙江 哈尔滨 150036;黑龙江省中医药大学附属第一医院眼科 黑龙江 哈尔滨 150040
基金项目:黑龙江省教育厅科学技术研究项目(12511311)
摘    要:目的:探讨布林佐胺联合噻吗洛尔治疗开角型青光眼的临床效果及安全性。方法:选择2016年9月至2018年9月在我院接受治疗的150例开角型青光眼患者,采用抽签法分为观察组(n=76)和对照组(n=74)。对照组给予噻吗洛尔治疗,观察组在对照组的基础上给予布林佐胺治疗。比较两组患者的临床疗效、治疗前后眼压、视野平均光敏度、视野平均缺损、视网膜神经纤维层厚度(RNFLT)、视盘盘沿面积(NRA)、泪膜破裂时间(BUT)、收缩期峰值血流速度(PSV)、舒张末期血流速度(EDV)及阻力系数(RI)水平的变化及并发症的发生情况。结果:治疗后,观察组和对照组总有效率分别为96.72%,79.66%,观察组显著高于对照组(P0.05);观察组眼压、视野平均光敏度、视野平均缺损水平及RI均显著低于对照组(P0.05),PSV、EDV、BUT显著高于对照组(P0.05)。两组并发症总发生率分别为3.95%、9.46%,差异无统计学意义(P0.05)。结论:布林佐胺联合噻吗洛尔用于开角型青光眼患者的效果显著,可有效改善患者眼压、视敏度,且安全性较高。

关 键 词:布林佐胺  噻吗洛尔  慢性鼻窦炎  开角型青光眼  安全性
收稿时间:2020/1/23 0:00:00
修稿时间:2020/2/18 0:00:00

Curative Efficacy of Brinzolamine Combined with Timolol in the Treatment of Open Angle Glaucomaand Its Safety
LIU F,HAO Jing,CHEN Zhi-jie,LIU Jiang,ZHANG Xiao-lei,YAO Jing.Curative Efficacy of Brinzolamine Combined with Timolol in the Treatment of Open Angle Glaucomaand Its Safety[J].Progress in Modern Biomedicine,2020(11):2189-2192.
Authors:LIU F  HAO Jing  CHEN Zhi-jie  LIU Jiang  ZHANG Xiao-lei  YAO Jing
Institution:Department of Ophthalmology, Harbin 242 Hospital, AVIC, Harbin, Heilongjiang, 150066, China;College of Adult Education, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150036, China; Department of Ophthalmology, the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, China
Abstract:ABSTRACT Objective: To study the curative efficacy of brinzolamine combined with timolol in the treatment of open angle glaucoma and its safety. Methods: 150 patients with open-angle glaucoma who were treated in our hospital from September 2016 to September 2018 were selected and divided into the observation group (n=76) and the control group (n=74) by lottery. The control group was treated with timolol, and the observation group was treated with brinzolamine on the basis of control group. The clinical curative effect, the average intraocular pressure, vision light sensitivity, average visual defect, retinal nerve fiber layer thickness (RNFLT) along the area (NRA), it appears, DVD disk rupture time (BUT), systolic peak velocity (PSV), end-diastolic velocity (EDV), the change of drag coefficient (RI) levels and the occurrence of complications were compared between the two groups before and after treatment. Results: After treatment, the total effective rate of observation group and control group was 96.72% and 79.66%, respectively, which was significantly higher in the observation group than that in the control group(P<0.05). The iop, average photosensitivity of visual field, average defect level of visual field and RI in the observation group were significantly lower than those in the control group(P<0.05), while the PSV, EDV and BUT were significantly higher than those in the control group(P<0.05). The total incidence of complications in the two groups was 3.95% and 9.46%, respectively, with no statistically significant difference(P<0.05). Conclusion: Brinzolamide combined with timolol has a remarkable effect on patients with open-angle glaucoma, which can effectively improve the intraocular pressure and visual acuity of the patients with high safety.
Keywords:Brinzoamine  Timolol  Chronic sinusitis  Open Angle glaucoma  Security
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号